Phreesia Inc is a healthcare technology company that focuses on transforming the patient experience. It provides a software platform designed to streamline patient intake processes, enhance communication between patients and healthcare providers, and improve overall administrative efficiency within medical practices. By offering solutions such as patient surveys, appointment scheduling, and payment processing, Phreesia aims to optimize workflows, increase patient engagement, and ultimately contribute to better health outcomes. The company is committed to empowering both patients and providers through innovative technology that enhances the healthcare journey. Read More
Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Other gainers include Snowflake, Genius Group, and Astrotech.
Phreesia (NYSE:PHR) reported higher first-quarter revenue and profitability for fiscal 2027, with executives pointing to growth in payment solutions, expanding opportunities from its AccessOne acquisition and continued investment in patient intake, provider engagement and artificial intelligence.
O
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”). Phreesia investors have until July 13, 2026 to file a lead plaintiff motion.
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) investors of the July 13, 2026 deadline to seek the role of lead plaintiff in a pending federal securities class action. Courts do not consider applications filed after this deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions.
NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”). Phreesia investors have until July 13, 2026 to file a lead plaintiff motion.
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased or otherwise acquired Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026, inclusive (the “Class Period”). Phreesia investors have until July 13, 2026 to file a lead plaintiff motion.
Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) investors concerning the Company’s possible violations of the federal securities laws.
LOS ANGELES, May 22, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Law Offices of Howard G. Smith announces an investigation on behalf of Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) investors concerning the Company’s possible violations of federal securities laws.
NEW YORK, May 21, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
The Law Offices of Frank R. Cruz announces an investigation of Phreesia Inc. (“Phreesia” or the “Company”) (NYSE: PHR) on behalf of investors concerning the Company’s possible violations of federal securities laws.
NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
LOS ANGELES, May 19, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Phreesia, Inc. (“Phreesia” or “the Company”) (NYSE: PHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE:PHR) securities during the period of May 8, 2025 through March 30, 2026, inclusive (“the Class Period”).
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Phreesia (PHR) To Contact Him Directly To Discuss Their Options
Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Phreesia, Inc. (NYSE: PHR) between May 8, 2025 and March 30, 2026. Phreesia describes itself as a company that “provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.”
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Phreesia, Inc. (NYSE: PHR) common stock between May 8, 2025 and March 30, 2026. Phreesia provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada.
